{"id":23279,"date":"2024-03-19T08:57:59","date_gmt":"2024-03-19T07:57:59","guid":{"rendered":"https:\/\/ggba.swiss\/perivision-registers-vr-ai-based-eye-testing-platform-visionone-with-us-fda\/"},"modified":"2024-03-19T09:03:12","modified_gmt":"2024-03-19T08:03:12","slug":"perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/","title":{"rendered":"PeriVision enregistre sa plateforme de test oculaire bas\u00e9e sur la RV et l’IA aupr\u00e8s de la FDA"},"content":{"rendered":"\n

Le projet de PeriVision<\/a>, qui visait \u00e0 d\u00e9mocratiser l’acc\u00e8s aux soins oculaires avanc\u00e9s, a permis de combler une lacune cruciale dans les diagnostics et les traitements ophtalmologiques gr\u00e2ce \u00e0 VisionOne<\/a>. Lanc\u00e9e l’ann\u00e9e derni\u00e8re, la plateforme a \u00e9t\u00e9 con\u00e7ue pour simplifier les examens oculaires gr\u00e2ce \u00e0 l’utilisation de casques VR portables, offrant ainsi une solution moderne aux m\u00e9thodes traditionnelles encombrantes et souvent inaccessibles. Avec VisionOne, les professionnels peuvent non seulement effectuer des tests oculaires plus efficacement, mais aussi acc\u00e9der aux r\u00e9sultats et les analyser gr\u00e2ce \u00e0 une plateforme cloud sophistiqu\u00e9e. Le backend est aliment\u00e9 par des algorithmes d’IA qui affinent les tests oculaires, assurent le contr\u00f4le de la qualit\u00e9, automatisent l’assistance et fournissent des informations cruciales pour les d\u00e9cisions cliniques.<\/p>\n\n\n\n

L’obtention de l’enregistrement aupr\u00e8s de la FDA constitue une validation significative de l’engagement de PeriVision \u00e0 respecter les normes les plus \u00e9lev\u00e9es en mati\u00e8re de s\u00e9curit\u00e9, d’efficacit\u00e9 et de qualit\u00e9 des logiciels m\u00e9dicaux. Le Dr Ernest Cavin, membre du conseil d’administration ayant une grande exp\u00e9rience de l’ophtalmologie, a soulign\u00e9 que l’enregistrement \u00e9tait l’aboutissement d’une recherche et d’un d\u00e9veloppement rigoureux et de collaborations avec des institutions de premier plan.<\/p>\n\n\n\n

Des solutions concr\u00e8tes pour relever les d\u00e9fis mondiaux en mati\u00e8re de sant\u00e9<\/h4>\n\n\n\n

Les technologies d’IA, de RV et de suivi oculaire de VisionOne r\u00e9pondent aux besoins pressants de la communaut\u00e9 ophtalmologique. Ciblant sp\u00e9cifiquement le diagnostic et le suivi du glaucome – une cause majeure de c\u00e9cit\u00e9 irr\u00e9versible affectant plus de 80 millions de personnes dans le monde – VisionOne vise \u00e0 r\u00e9volutionner les tests du champ visuel. Dans le communiqu\u00e9 de presse, le Dr Kevin Gillmann, directeur m\u00e9dical de PeriVision et sp\u00e9cialiste du glaucome, souligne que l’enregistrement du dispositif n’est qu’un d\u00e9but. La soci\u00e9t\u00e9 aspire \u00e0 \u00e9largir son portefeuille avec une suite compl\u00e8te de tests oculaires et d’outils d’IA con\u00e7us pour am\u00e9liorer la productivit\u00e9 des cliniques, la gestion des maladies et l’exp\u00e9rience des patients.<\/p>\n\n\n\n

Avec l’approbation de la FDA maintenant en main, PeriVision peut pr\u00e9senter ses soins de pointe aux prestataires de soins de sant\u00e9. L’entreprise devrait pr\u00e9senter VisionOne lors de la prochaine Vision Expo East \u00e0 New York, signalant ainsi qu’elle est pr\u00eate \u00e0 transformer le paysage des diagnostics et des soins ophtalmologiques.<\/p>\n","protected":false},"excerpt":{"rendered":"

PeriVision, une spin-off de l’Universit\u00e9 de Berne et de l’H\u00f4pital universitaire de Berne, a annonc\u00e9 l’enregistrement de sa plateforme VisionOne aupr\u00e8s de la FDA.<\/p>\n","protected":false},"author":6,"featured_media":23276,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[845],"tags":[1179,1180,1152,1181,1163],"class_list":["post-23279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech","tag-artificial-intelligence-fr-2","tag-digital-health-fr-2","tag-digital-transformation-fr","tag-medical-devices-fr","tag-medtech-fr-2"],"acf":[],"yoast_head":"\nPeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA<\/title>\n<meta name=\"description\" content=\"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA\" \/>\n<meta property=\"og:description\" content=\"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-19T07:57:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-19T08:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"PeriVision enregistre sa plateforme de test oculaire bas\u00e9e sur la RV et l’IA aupr\u00e8s de la FDA\",\"datePublished\":\"2024-03-19T07:57:59+00:00\",\"dateModified\":\"2024-03-19T08:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\"},\"wordCount\":438,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Digital Transformation\",\"Medical Devices\",\"Medtech\"],\"articleSection\":[\"Tech\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\",\"name\":\"PeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png\",\"datePublished\":\"2024-03-19T07:57:59+00:00\",\"dateModified\":\"2024-03-19T08:03:12+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"La plateforme innovante de PeriVision associe la r\u00e9alit\u00e9 virtuelle (VR) et l'intelligence artificielle (AI) afin de moderniser et d'am\u00e9liorer les tests oculaires pour les ophtalmologues et les optom\u00e9tristes. | \u00a9 PeriVision\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PeriVision enregistre sa plateforme de test oculaire bas\u00e9e sur la RV et l’IA aupr\u00e8s de la FDA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA","description":"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/","og_locale":"fr_FR","og_type":"article","og_title":"PeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA","og_description":"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.","og_url":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-03-19T07:57:59+00:00","article_modified_time":"2024-03-19T08:03:12+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"PeriVision enregistre sa plateforme de test oculaire bas\u00e9e sur la RV et l’IA aupr\u00e8s de la FDA","datePublished":"2024-03-19T07:57:59+00:00","dateModified":"2024-03-19T08:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/"},"wordCount":438,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png","keywords":["Artificial Intelligence","Digital Health","Digital Transformation","Medical Devices","Medtech"],"articleSection":["Tech"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/","url":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/","name":"PeriVision enregistre sa plateforme VisionOne aupr\u00e8s de la FDA","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png","datePublished":"2024-03-19T07:57:59+00:00","dateModified":"2024-03-19T08:03:12+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"PeriVision a annonc\u00e9 l'enregistrement de sa plateforme de test oculaire bas\u00e9e sur la RV et l'IA, VisionOne, aupr\u00e8s de la FDA.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/03\/PeriVision-1180x811-1.png","width":1180,"height":811,"caption":"La plateforme innovante de PeriVision associe la r\u00e9alit\u00e9 virtuelle (VR) et l'intelligence artificielle (AI) afin de moderniser et d'am\u00e9liorer les tests oculaires pour les ophtalmologues et les optom\u00e9tristes. | \u00a9 PeriVision"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/perivision-enregistre-sa-plateforme-de-test-oculaire-basee-sur-la-rv-et-lia-aupres-de-la-fda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"PeriVision enregistre sa plateforme de test oculaire bas\u00e9e sur la RV et l’IA aupr\u00e8s de la FDA"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=23279"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23279\/revisions"}],"predecessor-version":[{"id":23281,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/23279\/revisions\/23281"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/23276"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=23279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=23279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=23279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}